News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

06/02/2020 | Insilico Biotechnology AG

Towards the Smart Biofactory: Insilico Biotechnology AG and Three Space Lab join forces

(Stuttgart) Insilico Biotechnology AG and Three Space Lab LLC, provider of collaborative virtual reality solutions, announce their collaboration to implement a 3D virtual Digital Twin as a key building block for a modular smart biofactory.
05/28/2020 | Atriva Therapeutics GmbH

Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study

ATR-002 mode of action inhibits SARS-CoV-2 viral propagation and prevents the cytokine storm as demonstrated in preclinical studies Atriva’s lead product candidate is the only host-targeted antiviral specifically developed to treat respiratory infections with RNA viruses, such as influenza virus and the novel SARS-CoV-2 With i...
05/20/2020 | Syntegon Technology GmbH

Covid-19: Get ready for production!

Now is the right time to get ready for production of a vaccine against Covid-19. We can offer the ideal solution.
05/19/2020 | Bosch Healthcare Solutions GmbH

BioGX, Bosch Healthcare Solutions partner to expand molecular diagnostic tests offering for the Vivalytic platform

New biocontent cooperation with renowned US firm Bosch Healthcare Solutions and BioGX announce partnership for point of care molecular tests Partnership will accelerate planned expansion of the test portfolio for the Vivalytic all-in-one platform    
05/12/2020 | Universität Stuttgart

How Covid-19 Testing Can Become More Efficient

Mathematical Decision Support that calculates which method is most effective in identifying all Covid-19 patients in a positive sample pool With the help of so-called pooling procedures, samples from different people can be combined into a pool and tested for Covid-19 collectively in a single test kit. An interdisciplinary team of mathematicians...
05/12/2020 | Mediagnost GmbH

Mediagnost Anti-SARS-CoV-2 ELISA is CE marked

Mediagnost has developed a test procedure that can detect antibodies against the new SARS-CoV-2 in human blood. The Anti-SARS-CoV-2 ELISA has been CE marked since May 6, 2020.
05/06/2020 | Universität Stuttgart

A feeling for touch screens

Researchers at the University of Stuttgart are developing electro-tactile touch user interfaces for older people – test subjects wanted The use of touch screens is often difficult, especially for older people, since the information is captured primarily with the eye, but not with the sense of touch. Researchers at the Institute for Engineering D...
05/04/2020 | Deutsche Institute für Textil- und Faserforschung (DITF)

DITF produce nonwovens for certified FFP 2 protective masks

Research pilot plant was converted for production As of this week, it is mandatory to wear masks on buses and trains and when shopping in Germany. However, protective masks are still in short supply. While simple mouth and nose covers are currently sufficient for everyday life, FFP 2 or FFP 3 masks are urgently needed in hospitals and in the car...
04/28/2020 | Universität Stuttgart

The university of Stuttgart will be the first European location in the IBM AI Horizons Network

The aim is to develop an automated interface between unstructured and structured data
04/27/2020 | 4base lab AG

4base lab supports Corona Tests

In the current SARS-CoV-2 pandemic, 4base lab AG supports pharmaceutical manufacturers in their efforts to bring modern corona vaccines timely into clinical trials. 4base lab runs laboratories according to GMP standards and provides its expertise in drug analysis of mRNA- or DNA vaccines.
04/22/2020 | xPhyto Therapeutics Corp.

Infectious disease oral dissolvable biosensor development

Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to its press release on April 20, 2020, regarding a definitive development, technology purchase and licence agreement (the “Agreement”) with 3a-Diagnostics GmbH (“3a”), XPhyto’s wholly owned...


Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF)(“XPhyto” or the “Company”) is pleased to announce that it has signed a definitive development, technology purchase and licence agreement (the “Agreement”) with 3a-Diagnostics GmbH (“3a”) for the development and commercialization of real-time, low-cost an...
04/20/2020 | Curetis GmbH

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Curetis N.V. in liquidatie (the "Company") announces that the liquidators of the Company have resolved upon a liquidation distribution in advance
04/16/2020 | OpGen, Inc.

OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study

Peer-reviewed study evaluated performance of AI-powered bioinformatics cloud platform,, for NGS-based antibiotic susceptibility testing on 12 pathogenic bacterial species and 21 antibiotic drugs   NGS-based testing reache...
04/09/2020 | Evaluate Ltd.

Virtual partnering event launched to accelerate partnerships in the life sciences industry to fight against COVID-19

COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April – 06 May  The initiative is backed by a consortium of biotech clusters and leading trade associations in the life sciences industry and represents a practical way to accelerate partnerships to develop and deliver solutions against COVID-19 ...
04/03/2020 | European Commission

Commission postpones application of the Medical Devices Regulation to prioritise the fight against coronavirus

Today, the European Commission has adopted a proposal to postpone by one year the date of application of the Medical Devices Regulation to allow Member States, health institutions and economic operators to prioritise the fight against the coronavirus pandemic.
04/02/2020 | CureVac AG

Jean Stéphenne Elected as New Chairman of the Supervisory Board of CureVac

CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Jean Stéphenne, former deputy Chairman of the Supervisory Board, has been appointed as the new Chairman with immediate effect. Jean Stéphenne has been a member of the Board since September 2015.
04/01/2020 | Curetis GmbH

Curetis and OpGen Close Business Combination

Following approval of shareholders, companies sign German transfer agreement Curetis GmbH and its subsidiaries Curetis USA Inc.and Ares Genetics GmbH are now wholly owned by OpGen, Inc. OpGen consideration shares to be distributed to Curetis N.V. shareholders and Curetis N.V. to be dissolved and delisted from Euronex Three Curetis N.V. Sup...
Synovo GmbH

Availability of SARS-CoV-2 assays and Covid-19 immunity profiling.

Synovo GmbH has implemented the CDC assay for the detection of SARS-CoV-2 – the agent causing the Covid-19 outbreak.